The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; Relationship to the cell-mediated immune response

被引:24
作者
Rodriguez, V
Centeno, M
Ulrich, M
机构
[1] Section of Immunology II, Instituto de Biomedicina, Caracas 1010A
关键词
Leishmania; IgG isotypes; leishmaniasis;
D O I
10.1046/j.1365-3024.1996.d01-113.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
American cutaneous leishmaniasis (ACL) presents a spectrum of clinical and immunological manifestations. Since the nature of the cellular response appeals to play a fundamental role in determining the characteristics of the immunoglobulin isotype of specific antibody responses, we have compared the relative levels of specific antibodies of the four IgG isotypes against Leishmania in sera from patients with different clinical manifestations of ACL. Using a specific antibody capture assay, significant levels of antibodies of the IgG1, 2 and 3 isotypes were detected in localized cutaneous leishmaniasis (LCL); the average level of IgG4 antibodies was low and they were not detected in 10/20 sera. Sera from muco-cutaneous leishmaniasis (MCL) gave a comparatively strong IgG1 response. Sera from diffuse cutaneous leishmaniasis (DCL), the rare form characterized by antigen-specific anergy of cell-mediated immunity, showed highly significant levels of IgG4 antibodies compared to antibody levels of this isotype in the other groups; IgG1 and IgG2 levels were also elevated. Based on other studies of the relationship between the IgG isotype response and cell-mediated immunity, these results confirm a Th1-like CD4(+) T cell response in LCL and MCL and a significant Th2-like response in DCL.
引用
收藏
页码:341 / 345
页数:5
相关论文
共 22 条
[1]   THE STRUCTURAL REQUIREMENTS FOR COMPLEMENT ACTIVATION BY IGG - DOES IT HINGE ON THE HINGE [J].
BREKKE, OH ;
MICHAELSEN, TE ;
SANDLIE, I .
IMMUNOLOGY TODAY, 1995, 16 (02) :85-90
[2]  
BRODILDEN PA, 1989, CLIN EXPT IMMUNOLOGY, V76, P216
[3]  
CABRERA Z, 1988, CLIN EXP IMMUNOL, V74, P223
[4]  
CACERESDITTMAR G, 1993, CLIN EXP IMMUNOL, V91, P500, DOI 10.1111/j.1365-2249.1993.tb05931.x
[5]   T-CELL SUBPOPULATIONS, EXPRESSION OF INTERLEUKIN-2 RECEPTOR, AND PRODUCTION OF INTERLEUKIN-2 AND GAMMA-INTERFERON IN HUMAN AMERICAN CUTANEOUS LEISHMANIASIS [J].
CASTES, M ;
CABRERA, M ;
TRUJILLO, D ;
CONVIT, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (06) :1207-1213
[6]   CHARACTERIZATION OF THE CELLULAR IMMUNE-RESPONSE IN AMERICAN CUTANEOUS LEISHMANIASIS [J].
CASTES, M ;
AGNELLI, A ;
VERDE, O ;
RONDON, AJ .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 27 (02) :176-186
[7]  
Convit J, 1993, Biol Res, V26, P159
[8]   THE CLINICAL AND IMMUNOLOGICAL SPECTRUM OF AMERICAN CUTANEOUS LEISHMANIASIS [J].
CONVIT, J ;
ULRICH, M ;
FERNANDEZ, CT ;
TAPIA, FJ ;
CACERESDITTMAR, G ;
CASTES, M ;
RONDON, AJ .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1993, 87 (04) :444-448
[9]  
CONVIT J, 1974, CIBA F S, V20, P159
[10]  
DHANDAYUTHAPANI S, 1992, CLIN EXP IMMUNOL, V88, P253, DOI 10.1111/j.1365-2249.1992.tb03069.x